Evidence map›Paper›PMID 40620294›Full record

ArticleChina CDC weekly2025

Impact of Comprehensive Strategy on Mortality in Heterosexually Transmitted HIV-Infected Individuals - Liangshan Prefecture, Sichuan Province, China, 2008-2024.

Ruiying Liang, Fangfang Chen, Yan Zhao, Ju Wang, Decai Zhao, Jiejun Yu, Houlin Tang, Jian Li, Zhongfu Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruiying LiangNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Fangfang ChenNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yan ZhaoNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ju WangLiangshan Prefecture Center for Disease Control and Prevention, Xichang City, Sichuan Province, China.
Decai ZhaoNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jiejun YuNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Houlin TangNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jian LiNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhongfu LiuNational Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A comprehensive strategy integrating universal human immunodeficiency virus (HIV) testing, real-time patient tracking, and enhanced antiretroviral therapy (ART) within a poverty-alleviation framework was implemented to curb the HIV epidemic in Liangshan Prefecture. This study aimed to quantify its impact on HIV treatment coverage and mortality among heterosexually transmitted HIV-infected individuals. Data on heterosexually transmitted HIV infections in Liangshan from 2008 to 2024 were extracted from China's HIV/acquired immunodeficiency syndrome (AIDS) Comprehensive Response Information Management System (CRIMS) database. Cox proportional hazards models were used to estimate the effectiveness of the comprehensive strategy on mortality. Interrupted time series analysis examined trends and changes in treatment coverage and mortality before and after implementation. Subgroup analysis investigated outcomes variations across different populations. Among 37,034 eligible HIV-infected individuals, 7,302 deaths occurred. Not receiving ART was the strongest risk factor for mortality [hazard ratio (

Indexed as

AIDSantiretroviral therapy (ART)interrupted time series (ITS)mortality rate

Identifiers

PMID40620294
PMCPMC12228074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.